Financial Times

Investor quits Sulake after sex claim

Balderton has dumped its 13.5% stake in the Finnish group after allegations that one of its sites was playing host to sexually explicit content

Deutsche Bank's co-chief executive addresses politicians and business leaders in Berlin in a show of commitment to the bank's domestic market

The UK group is to pay at least £146m for Toctino, an oral medication developed by Basilea, as it seeks to diversify its dermatology division

The company plans to make direct loans to European commercial property developers, taking advantage of a slowdown in lending by European banks

Page 218 of 266